SL-401 (tagraxofusp)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SL-401 (tagraxofusp), covering 2024-08-21 to 2024-08-21. Get the full timeline:
Most recent: Clinical Trial Update: SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission [Phase 1, Phase 2]